PitchCentric
Reprogrammed: A biotechnology Podcast
Updated 12 days ago · Refreshed hourly
education

Reprogrammed: A biotechnology Podcast

Hosted by Jack Treml · 🇺🇸 US · EN · 21 episodes

Where this show ranks

Episodes
21
Last ep.
12 days ago
Avg length
19m
Booking Probability™
37
Stretch.
Sign in to score against your profile.
Estimated audience
,
Audience size not yet estimated
Listen Score
19
Niche reach.
Virality (30d)
48
Steady cadence.

Pitch Analysis

Sign in to see how your Guest Score compares to this show's Required Pod Score and get a Stretch / Match-fit / Anchor verdict.
Required Pod Score
80/ 100
Premium

Established thought leaders with verified media credentials.

Guest openness
Not signalled recently
Best topics to pitch
education

About this podcast

Reprogrammed in a biotechnology podcast that explores a new topic every season through examining a series of seminal papers. This podcast supports a Selected Topics in Biotechnology course at the University of Kansas' Edwards Campus - but you don't need to be in that course to listen!

education

About the host

Jack Treml hosts Reprogrammed: A biotechnology Podcast, a education show with 21 episodes published.

Recent episodes

Our AI reads these to draft pitches

S2Ep10: Interview with Dr. Maria Deza Leon

May 14, 202642mEp. 10S2

This interview followed a Keynote speech Dr. Deza Leon gave at the 2026 Hawk Talks Event at KU Edwards Campus on May 1.

Show notes

S2Ep9: What’s in the Box: the making of a damn fine vaccine

Apr 13, 202621m0

This episode looks at two papers, one a 2019 paper by Hassett et al. about optimizing Lipid Nanoparticles specifically for intramuscular mRNA vaccines. And a second, Laczko et al., from 2020, that shows what kind of immu

Show notes

S2Ep7: Something looks off here

Mar 29, 202620mEp. 7S2

This episode discusses the 2005 Kariko et al. paper about RNA immunogenicity.

Show notes

S2Ep6: How to Outpace a Killer Virus

Mar 9, 202619mEp. 6S2

In this episode, we explain why influenza is such a persistent threat—its segmented RNA genome enables antigenic drift and reassortment-driven “shift,” letting it change faster than traditional vaccines can be manufactur

Show notes

S2Ep5: The call is coming from inside the house

Mar 4, 202626mEp. 5S2

mRNA vaccines: when the call is coming from inside the house, discusses how the immune system knows what's going on inside of cells and how specific that knowledge is. This episode explains MHC Haplotype and how MHC rest

Show notes

Show me the CTLs

Feb 26, 202622mEp. 4S2

This episode explores an early mRNA vaccination study showing that injected RNA can be injected into the body, be translated into protein that is presented on MHC class I to generate an antigen-specific cytotoxic T-cell

Show notes

Programmable Immunity

Feb 17, 202615mEp. 12S1

This week on Reprogrammed, Jack and Annie tackle a key limitation in CAR T cell therapy for solid tumors: poor trafficking to the tumor site. Centered on the 2010 study by Craddock et al., this episode explores how engin

Show notes

Rational Design for persistence

Feb 17, 202625mEp. 11S1

In this episode, we examine the work of Roselli et al.1, who explore a critical frontier in CAR T cell engineering: how to build T cells that don’t just kill tumors effectively, but also survive, persist, and adapt in th

Show notes

Shifting Gears

Feb 17, 202611mEp. 10S1

Over the past episodes of Reprogrammed, we’ve followed the rapid evolution of CAR T cell therapy—from early experiments demonstrating that antibody-based chimeric receptors could trigger T cell activation and IL-2 produc

Show notes

Dude, where's my CAR construct?

Feb 17, 202613mEp. 9S1

Over the past episodes of Reprogrammed, we’ve followed the rapid evolution of CAR T cell therapy—from early experiments demonstrating that antibody-based chimeric receptors could trigger T cell activation and IL-2 produc

Show notes

What? Another Brentjens paper?

Feb 17, 202611mEp. 8S1

Reprogrammed is a biotechnology podcast exploring the development of cell therapies, with this season focusing on CAR T cells in cancer treatment. The Brentjens et al. (2013) study marked a pivotal moment in the clinical

Show notes

IL-15 and B7 co-stimulation

Feb 17, 202611mEp. 7S1

This podcast delves into the exciting world of cancer immunotherapy, focusing on the evolution of cancer vaccines and the recent surge of cell-based therapies. This series follows a string of primary research papers high

Show notes

First Gen CAR T Cells

Feb 17, 202613mEp. 6S1

This podcast delves into the exciting world of cancer immunotherapy, focusing on the evolution of cancer vaccines and the recent surge of cell-based therapies. This series follows a string of primary research papers high

Show notes

Incorporating co-stimulatory signaling in CAR T Cells

Feb 17, 202619mEp. 5S1

This podcast delves into the exciting world of cancer immunotherapy, focusing on the evolution of cancer vaccines and the recent surge of cell-based therapies. This series follows a string of primary research papers high

Show notes

Season2 Episode3: Tang et al. use a gene gun for plasmid DNA bombardment

Feb 15, 202618mEp. 3S2

This is the first paper to demonstrate that plasmid DNA injections elicited humoral immune responses and could therefore function as vaccines.

Show notes

Ep 4: Hijacking T Cells

Feb 10, 202614m0

This episode addresses the question of whether lymphocytes can be harvested, reprogrammed in their specificity for a selected tumor antigen ex vivo, and then re-administered to the patient to combat their cancer. The fir

Show notes

Ep 3: Th Model T of CAR T Cells

Feb 10, 202612mEp. 1S3

This episode addresses the question of whether lymphocytes directed against one specific tumor antigen can be manipulated to better combat cancer. The first paper, from 1989, examines cells initially generated in an anim

Show notes

Ep 2: Oh, you mean I'm getting cancer all the time?

Feb 10, 202623mEp. 2S1

Introduction of key papers:o 1974 article by Israel Penn, MD, on cancer in immune deficiencies.2020 article by Hegde et al. on dendritic cells and immune surveillance.• Framing question: “Does the immune system operate t

Show notes

Ep 1: Get in the CAR loser, we're curing cancer

Feb 10, 202627mEp. 1S1

This podcast delves into the exciting world of cancer immunotherapy, focusing on the evolution of cancer vaccines and the recent surge of cell-based therapies. It begins with a brief historical overview, highlighting the

Show notes

Ep 1: Making something out of Nothing

Feb 10, 202613mEp. 1S2

This episode relates to: the 1990 Wolff et al., paper in Science,247(4949 Pt 1):1465–1468. Direct Gene Transfer into Mouse Muscle in Vivo and the 1993 Ulmer et al., paper in Science, 259(5102):1745–1749. Heterologous pro

Show notes

Sponsors and advertisers

Sponsor detection runs nightly. Check back soon.

Audience demographics

Age
25-54
Consumer type
Lifelong learners

Topics covered

education

Successful pitch examples

No public pitch examples yet for this show.

Generate your own personalised pitch

Best industries to pitch Reprogrammed: A biotechnology Podcast for

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.

Similar podcasts to Reprogrammed: A biotechnology Podcast

Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.

Frequently asked questions

How do I pitch Reprogrammed: A biotechnology Podcast as a podcast guest?

To pitch Reprogrammed: A biotechnology Podcast, visit https://podcasters.spotify.com/pod/show/jack-treml for contact information, then craft a tight one-paragraph hook that ties your expertise to a gap in their recent education coverage.

Who is the host of Reprogrammed: A biotechnology Podcast?

Reprogrammed: A biotechnology Podcast is hosted by Jack Treml. The show is categorised under education and has published 21 episodes.

How many episodes does Reprogrammed: A biotechnology Podcast have?

Reprogrammed: A biotechnology Podcast has published 21 episodes.

What topics does Reprogrammed: A biotechnology Podcast cover?

Reprogrammed: A biotechnology Podcast regularly covers education. It sits in the education category.

Is it hard to get booked on Reprogrammed: A biotechnology Podcast?

Reprogrammed: A biotechnology Podcast is accessible for guests with genuine education expertise. A personalised, episode-aware pitch will still outperform a generic one every time.

Is Reprogrammed: A biotechnology Podcast currently accepting guest pitches?

Reprogrammed: A biotechnology Podcast hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.

How long are Reprogrammed: A biotechnology Podcast episodes?

Episodes of Reprogrammed: A biotechnology Podcast average 19 minutes. a focused format where a clear narrative arc and tight preparation matter most.

What guest credentials does Reprogrammed: A biotechnology Podcast typically look for?

Our data rates Reprogrammed: A biotechnology Podcast's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.

Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 12 days ago.

Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.